Quick Answer
Camp4 Therapeutics Corp reported Earnings Per Share Diluted of $2.65 (loss) per share for the year ending 2025.
- Camp4 Therapeutics Corp showed an increase of +76.0% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from Camp4 Therapeutics Corp's annual report (Form 10-K), filed with the SEC on March 5, 2026.
- XBRL data for this metric is available from 2023 to 2025 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 3 years of available data (2023 to 2025), Camp4 Therapeutics Corp's Earnings Per Share Diluted has grown by 97.9%.
- Historical annual values: Fiscal year 2025: $2.65 (loss) per share | Fiscal year 2024: $11.04 (loss) per share | Fiscal year 2023: $124.80 (loss) per share.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: